Echo Street Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,008
Closed -$934K 134
2023
Q3
$934K Buy
+10,008
New +$1.13M 0.01% 152
2023
Q2
Sell
-6,080
Closed -$706K 495
2023
Q1
$706K Buy
6,080
+3,243
+114% +$363K 0.01% 181
2022
Q4
$321K Buy
+2,837
New +$311K ﹤0.01% 395
2022
Q3
Sell
-110,070
Closed -$8.2M 591
2022
Q2
$8.2M Buy
+110,070
New +$10M 0.07% 100
2022
Q1
Sell
-625,996
Closed -$84M 644
2021
Q4
$84M Buy
625,996
+180,444
+40% +$25.9M 0.56% 79
2021
Q3
$60.9M Buy
+445,552
New +$56.2M 0.43% 89

Other funds holding DXCM

Echo Street Capital Management's DXCM Position: Q4 2023 in Review

Echo Street Capital Management sold out of DexCom (DXCM) in Q4 2023, closing a stake of 10,008 shares — an estimated $934K sold.

Echo Street Capital Management first reported a position in DXCM in Q3 2021 and held it in 6 quarters. The position peaked at $84M in Q4 2021. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Echo Street Capital Management reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Echo Street Capital Management sold 10,008 DexCom shares in Q4 2023, an estimated $934K.
  • Echo Street Capital Management first reported a position in DexCom in Q3 2021 and held it in 6 quarters.
  • Echo Street Capital Management's DexCom position peaked at $84M in Q4 2021.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.